3/17/2010 StockRing Buy-Sell-Hold Ratings for NASDAQ Biotechnology stocks

Receive FRESH Daily Updates for 16 StockRing Reports for $30/month !!!
   1. World Markets - 72 Indexes on 3/8/2010:  Buy   76% or 53 Hold   3% or 2 Sell   21% or 15 indexes 2. Dow Jones Index - 30 Stocks on 3/5/2010:  Buy   57% or 17 Hold   30% or 9 Sell   13% or 4 stocks
3. Best Brands - 200 stocks on 2/17/2010:  Buy   81% or 162 Hold   -1% or -2 Sell   20% or 39 stocks
4. S&P 500 Index - 500 Stocks on 7/21/2009:   Buy   68% or 341 Hold   21% or 106 Sell   11% or 53 stocks
5. S&P 400 Mid Cap - 400 Stocks on 7/21/2009:  Buy   73% or 292 Hold   15% or 61 Sell   12% or 47 stocks
6. S&P 600 Small Cap - 600 Stocks on 4/18/2009:  Buy   28% or 168 Hold   71% or 426 Sell   1% or 6 stocks
7. Nasdaq 100 Index - 100 Stocks on 7/21/2009:  Buy   75% or 75 Hold   17% or 17 Sell   8% or 8 stocks
8. Nasdaq Telecom - 164 Stocks on 7/24/2009:  Buy   49% or 81 Hold   35% or 56 Sell   16% or 27 stocks
9. Nasdaq Biotech - 136 Stocks on 7/24/2009:  Buy   57% or 78 Hold   33% or 45 Sell   10% or 13 stocks
10. Nasdaq Computer - 440 Stocks on 7/22/2009:  Buy   60% or 263 Hold   26% or 115 Sell   14% or 62 stocks
11. Nasdaq Finance - 180 Stocks on 7/24/2009:  Buy   61% or 109 Hold   6% or 12 Sell   33% or 59 stocks
12. NYSE International - 100 Stocks on 7/21/2009:  Buy   58% or 58 Hold   34% or 34 Sell   8% or 8 stocks
13. Legg Mason Mutual - 346 Funds on 10/6/2009:  Buy   38% or 133 Hold   51% or 176 Sell   11% or 37 funds
14. T. Row Price Mutual - 161 Funds on 10/6/2009:  Buy   52% or 84 Hold   46% or 73 Sell   2% or 4 funds
15. London FTSE 100 - 94 Stocks on 4/1/2009:  Buy   20% or 19 Hold   50% or 47 Sell   30% or 28 stocks
16. Canada Toronto - 209 Stocks on 4/18/2009:  Buy   53% or 111 Hold   34% or 70 Sell   13% or 28 stocks

                                             TOTAL RATINGS:   Buy   75% or 2183 Hold   5% or 1231 Sell   20% or 514 stocks

3/17/2010 StockRing Buy-Sell-Hold ratings for NASDAQ Biotechnology Index stocks
Our advise: SELL 10% or 13, HOLD 33% or 45, BUY 57% or 78 of NASDAQ Index stocks
All Sell & Super Sell Sell Super Sell Hold Buy & Super Buy Buy Super Buy
NASDAQ Biotechnology Index Chart for 1 year 3/17/2010 (Irvine, California) Today StockRing.com analyzed 136 stocks from NASDAQ Biotechnology Index and found that 10% or 13 got a SELL rating. Only 57% or 78 stocks got a BUY rating, while another 33% or 45 stocks got a HOLD rating out of all stocks from NASDAQ Biotechnology Index. Current Market outlook is extremely negative and we anticipate further market declines across all US and most World stocks market indexes. According to our model the government would not be able to compensate the market with enough liquidity to achieve normal operations. This would lead to even more declines in all major stock market sectors. By the way, StockRing found 2 stocks with SUPER SELL rating and 24 stocks with SUPER BUY rating. People who will suffer the most will be the owners of mutual fund shares. According to our scenario mutual funds will not be able quickly exit from their rapidly declining positions and would have to bear the most losses from more active players on the market. Also, a few very well organized stock market players are trading a lot in stock options and are securing currently very high prices for a lot of stocks while anticipating a major decline in their share prices. In the recent year the most profitable strategy was buying put options on all major stocks that consistently declined all year long from S&P 500 index in 2008. At this time StockRing recommends to buy SHORT positions on many stocks from S&P 500 Index stocks that currently have a SELL or SUPER SELL rating. If you decide to take a LONG position and actually buy some stocks right now - please check the section of S&P 500 index stocks that have a BUY or SUPER BUY rating. If you would like to receive Buy-Sell-Hold ratings specifically for your stocks and not just for stocks from S&P 500 Index, then please register for a Free 2 week trial with StockRing.com and begin receiving your weekly reports with Buy-Sell-Hold ratings for all your stocks! StockRing will completely automate your investment steps and quickly calculate which stocks you should SELL right now and which ones to BUY. All you have to do is sit and watch how StockRing software will manage and grow your invested wealth. Receive FRESH Daily Updates for 16 StockRing Reports for $30/month !!!
3/17/2010 StockRing Buy-Sell-Hold ratings for NASDAQ Biotechnology Index stocks
StockRing advise: SELL 10% or 13, HOLD 33% or 45, BUY 57% or 78 of NASDAQ Index stocks
All Sell & Super Sell Sell Super Sell Hold Buy & Super Buy Buy Super Buy
Symbol	Buy	Hold	Sell	Name	Last Trade		Change		Volume
1. ACAD				BUY - ACADIA Pharmaceuticals Inc. (NGM : ACAD)	Mar 16	1.64	0.00	0.00%
2. ACOR				HOLD - Acorda Therapeutics, Inc. (NGM : ACOR)	Mar 16	36.11	0.00	0.00%
3. ADLR				SELL - Adolor Corporation (NGM : ADLR)	Mar 16	2.09	0.00	0.00%
4. AFFX				HOLD - Affymetrix, Inc. (NasdaqNM : AFFX)	Mar 16	7.39	0.00	0.00%
5. AGEN				HOLD - Antigenics Inc. (NCM : AGEN)	Mar 16	0.7689	0.00	0.00%
6. AKRX				BUY - Akorn, Inc. (NGM : AKRX)	Mar 16	1.66	0.00	0.00%
7. ALKS				BUY - Alkermes, Inc. (NasdaqNM : ALKS)	Mar 16	13.62	0.00	0.00%
8. ALNY				HOLD - Alnylam Pharmaceuticals, Inc. (NasdaqNM : ALNY)	Mar 16	18.16	0.00	0.00%
9. ALTH				HOLD - Allos Therapeutics, Inc. (NGM : ALTH)	Mar 16	7.78	0.00	0.00%
10. ALTU				HOLD - Altus Pharmaceuticals Inc. (NGM : ALTU)	N/A	0.00	0.00	0.00%
11. ALXA				BUY - Alexza Pharmaceuticals, Inc. (NGM : ALXA)	Mar 16	2.90	0.00	0.00%
12. ALXN				BUY - Alexion Pharmaceuticals, Inc. (NasdaqNM : ALXN)	Mar 16	53.83	0.00	0.00%
13. AMAG				HOLD - AMAG Pharmaceuticals, Inc. (NGM : AMAG)	Mar 16	35.09	0.00	0.00%
14. AMGN				SUPER BUY - Amgen Inc. (NasdaqNM : AMGN)	Mar 16	57.42	0.00	0.00%
15. AMLN				SUPER BUY - Amylin Pharmaceuticals, Inc. (NasdaqNM : AMLN)	Mar 16	22.88	0.00	0.00%
16. AMRI				BUY - Albany Molecular Research, Inc. (NasdaqNM : AMRI)	Mar 16	8.56	0.00	0.00%
17. ANPI				HOLD - Angiotech Pharmaceuticals, Inc. (NasdaqNM : ANPI)	Mar 16	1.31	0.00	0.00%
18. ARIA				HOLD - ARIAD Pharmaceuticals, Inc. (NGM : ARIA)	Mar 16	3.48	0.00	0.00%
19. ARNA				BUY - Arena Pharmaceuticals, Inc. (NGM : ARNA)	Mar 16	3.00	0.00	0.00%
20. ARQL				BUY - ArQule, Inc. (NGM : ARQL)	Mar 16	3.60	0.00	0.00%
21. ARRY				BUY - Array BioPharma Inc. (NGM : ARRY)	Mar 16	2.69	0.00	0.00%
22. AUXL				BUY - Auxilium Pharmaceuticals, Inc. (NasdaqNM : AUXL)	Mar 16	32.94	0.00	0.00%
23. AVII				BUY - AVI BioPharma, Inc. (NGM : AVII)	Mar 16	1.30	0.00	0.00%
24. BCRX				HOLD - BioCryst Pharmaceuticals, Inc. (NGM : BCRX)	Mar 16	7.24	0.00	0.00%
25. BIIB				HOLD - Biogen Idec Inc (NasdaqNM : BIIB)	Mar 16	59.73	0.00	0.00%
26. BIOD				BUY - Biodel Inc. (NGM : BIOD)	Mar 16	4.43	0.00	0.00%
27. BJGP				BUY - BMP Sunstone Corporation (NGM : BJGP)	Mar 16	5.49	0.00	0.00%
28. BMRN				SELL - BioMarin Pharmaceutical Inc. (NasdaqNM : BMRN)	Mar 16	22.92	0.00	0.00%
29. BMTI				HOLD - BioMimetic Therapeutics, Inc. (NGM : BMTI)	Mar 16	12.90	0.00	0.00%
30. CADX				BUY - Cadence Pharmaceuticals, Inc. (NGM : CADX)	Mar 16	9.07	0.00	0.00%
31. CALP				HOLD - Caliper Life Sciences Inc (NGM : CALP)	Mar 16	3.65	0.00	0.00%
32. CBRX				SELL - Columbia Laboratories, Inc. (NGM : CBRX)	Mar 16	1.17	0.00	0.00%
33. CBST				BUY - Cubist Pharmaceuticals, Inc. (NasdaqNM : CBST)	Mar 16	22.71	0.00	0.00%
34. CEGE				HOLD - Cell Genesys, Inc. (NGM : CEGE)	N/A	0.36	0.00	0.00%
35. CELG				BUY - Celgene Corporation (NasdaqNM : CELG)	Mar 16	62.82	0.00	0.00%
36. CEPH				BUY - Cephalon, Inc. (NasdaqNM : CEPH)	Mar 16	70.80	0.00	0.00%
37. CERS				HOLD - Cerus Corporation (NGM : CERS)	Mar 16	2.85	0.00	0.00%
38. CRA				SELL - Celera Corporation (NasdaqNM : CRA)	Mar 16	6.96	0.00	0.00%
39. CRME				HOLD - Cardiome Pharma Corporation (NGM : CRME)	Mar 16	6.41	0.00	0.00%
40. CRXL				SUPER BUY - Crucell NV (NasdaqNM : CRXL)	Mar 16	21.44	0.00	0.00%
41. CRXX				HOLD - CombinatoRx, Incorporated (NGM : CRXX)	Mar 16	1.25	0.00	0.00%
42. CVTX				HOLD - CV Therapeutics, Inc. (NasdaqNM : CVTX)	N/A	0.00	0.00	0.00%
43. CYPB				BUY - Cypress Bioscience, Inc. (NGM : CYPB)	Mar 16	4.96	0.00	0.00%
44. CYTK				BUY - Cytokinetics, Incorporated (NGM : CYTK)	Mar 16	3.30	0.00	0.00%
45. DEPO				SUPER BUY - Depomed, Inc. (NGM : DEPO)	Mar 16	3.37	0.00	0.00%
46. DNDN				HOLD - Dendreon Corporation (NGM : DNDN)	Mar 16	36.48	0.00	0.00%
47. DRRX				HOLD - Durect Corporation (NGM : DRRX)	Mar 16	2.70	0.00	0.00%
48. DSCO				HOLD - Discovery Laboratories, Inc. (NGM : DSCO)	Mar 16	0.52	0.00	0.00%
49. DYAX				SUPER BUY - Dyax Corp. (NGM : DYAX)	Mar 16	4.03	0.00	0.00%
50. ENDP				BUY - Endo Pharmaceuticals Holdings I (NasdaqNM : ENDP)	Mar 16	24.03	0.00	0.00%
51. ENZN				BUY - Enzon Pharmaceuticals, Inc. (NGM : ENZN)	Mar 16	10.02	0.00	0.00%
52. EURX				BUY - Eurand N.V. (NGM : EURX)	Mar 16	11.16	0.00	0.00%
53. EXEL				BUY - Exelixis, Inc. (NasdaqNM : EXEL)	Mar 16	6.31	0.00	0.00%
54. FLML				BUY - Flamel Technologies S.A. (NGM : FLML)	Mar 16	8.07	0.00	0.00%
55. GENZ				SUPER SELL - Genzyme Corporation (NasdaqNM : GENZ)	Mar 16	57.33	0.00	0.00%
56. GERN				SUPER BUY - Geron Corporation (NGM : GERN)	Mar 16	6.23	0.00	0.00%
57. GHDX				SELL - Genomic Health, Inc. (NGM : GHDX)	Mar 16	19.61	0.00	0.00%
58. GILD				BUY - Gilead Sciences, Inc. (NasdaqNM : GILD)	Mar 16	47.47	0.00	0.00%
59. GNVC				BUY - GenVec, Inc. (NGM : GNVC)	Mar 16	2.78	0.00	0.00%
60. GPRO				HOLD - Gen-Probe Incorporated (NasdaqNM : GPRO)	Mar 16	46.46	0.00	0.00%
61. GTXI				HOLD - GTx, Inc. (NGM : GTXI)	Mar 16	3.43	0.00	0.00%
62. HALO				HOLD - Halozyme Therapeutics, Inc. (NGM : HALO)	Mar 16	7.43	0.00	0.00%
63. HBIO				BUY - Harvard Bioscience, Inc. (NGM : HBIO)	Mar 16	3.99	0.00	0.00%
64. HGSI				HOLD - Human Genome Sciences, Inc. (NGM : HGSI)	Mar 16	31.71	0.00	0.00%
65. HITK				SUPER BUY - Hi-Tech Pharmacal Co., Inc. (NasdaqNM : HITK)	Mar 16	22.84	0.00	0.00%
66. IDEV				HOLD - Indevus Pharmaceuticals Inc. (NasdaqNM : IDEV)	N/A	0.00	0.00	0.00%
67. IDIX				HOLD - Idenix Pharmaceuticals, Inc. (NGM : IDIX)	Mar 16	2.85	0.00	0.00%
68. ILMN				BUY - Illumina, Inc. (NasdaqNM : ILMN)	Mar 16	40.15	0.00	0.00%
69. IMGN				BUY - ImmunoGen, Inc. (NGM : IMGN)	Mar 16	7.39	0.00	0.00%
70. IMMU				HOLD - Immunomedics, Inc. (NGM : IMMU)	Mar 16	3.61	0.00	0.00%
71. INCY				SUPER BUY - Incyte Corporation (NGM : INCY)	Mar 16	12.99	0.00	0.00%
72. ISIS				BUY - Isis Pharmaceuticals, Inc. (NasdaqNM : ISIS)	Mar 16	9.80	0.00	0.00%
73. ISPH				BUY - Inspire Pharmaceuticals, Inc. (NGM : ISPH)	Mar 16	6.30	0.00	0.00%
74. ITMN				HOLD - InterMune, Inc. (NasdaqNM : ITMN)	Mar 16	37.73	0.00	0.00%
75. LGND				HOLD - Ligand Pharmaceuticals Incorpor (NGM : LGND)	Mar 16	1.91	0.00	0.00%
76. LIFE				SUPER BUY - Life Technologies Corporation (NasdaqNM : LIFE)	Mar 16	53.42	0.00	0.00%
77. LMNX				HOLD - Luminex Corporation (NGM : LMNX)	Mar 16	17.62	0.00	0.00%
78. LXRX				BUY - Lexicon Pharmaceuticals, Inc. (NGM : LXRX)	Mar 16	1.28	0.00	0.00%
79. MAXY				BUY - Maxygen, Inc. (NGM : MAXY)	Mar 16	6.15	0.00	0.00%
80. MBRK				BUY - MiddleBrook Pharmaceuticals, In (NGM : MBRK)	Mar 16	0.346	0.00	0.00%
81. MDCO				HOLD - Medicines Company (The) (NasdaqNM : MDCO)	Mar 16	8.26	0.00	0.00%
82. MDVN				BUY - Medivation, Inc. (NGM : MDVN)	Mar 16	12.61	0.00	0.00%
83. MEDX				HOLD - Medarex, Inc. (NGM : MEDX)	N/A	0.00	0.00	0.00%
84. MGRM				HOLD - Monogram Biosciences, Inc. (NGM : MGRM)	N/A	0.00	0.00	0.00%
85. MITI				SUPER BUY - Micromet, Inc. (NGM : MITI)	Mar 16	7.59	0.00	0.00%
86. MNKD				BUY - MannKind Corporation (NGM : MNKD)	Mar 16	7.59	0.00	0.00%
87. MNTA				SELL - Momenta Pharmaceuticals, Inc. (NGM : MNTA)	Mar 16	14.62	0.00	0.00%
88. MTXX				HOLD - Matrixx Initiatives Inc. (NasdaqNM : MTXX)	Mar 16	5.09	0.00	0.00%
89. MYGN				HOLD - Myriad Genetics, Inc. (NasdaqNM : MYGN)	Mar 16	25.49	0.00	0.00%
90. NABI				SUPER SELL - Nabi Biopharmaceuticals (NGM : NABI)	Mar 16	5.89	0.00	0.00%
91. NBIX				HOLD - Neurocrine Biosciences, Inc. (NasdaqNM : NBIX)	Mar 16	2.46	0.00	0.00%
92. NKTR				SUPER BUY - Nektar Therapeutics (NasdaqNM : NKTR)	Mar 16	15.37	0.00	0.00%
93. NOVN				HOLD - Noven Pharmaceuticals, Inc. (NasdaqNM : NOVN)	N/A	0.00	0.00	0.00%
94. NPSP				HOLD - NPS Pharmaceuticals, Inc. (NGM : NPSP)	Mar 16	3.97	0.00	0.00%
95. NVAX				BUY - Novavax, Inc. (NGM : NVAX)	Mar 16	2.31	0.00	0.00%
96. OMPI				SUPER BUY - Obagi Medical Products, Inc. (NasdaqNM : OMPI)	Mar 16	11.83	0.00	0.00%
97. ONXX				SUPER BUY - ONYX Pharmaceuticals, Inc. (NasdaqNM : ONXX)	Mar 16	32.46	0.00	0.00%
98. OPTR				SUPER BUY - Optimer Pharmaceuticals, Inc. (NGM : OPTR)	Mar 16	13.46	0.00	0.00%
99. OREX				SUPER BUY - Orexigen Therapeutics, Inc. (NGM : OREX)	Mar 16	6.53	0.00	0.00%
100. OSIP				BUY - OSI Pharmaceuticals Inc. (NasdaqNM : OSIP)	Mar 16	57.98	0.00	0.00%
101. OSIR				HOLD - Osiris Therapeutics, Inc. (NGM : OSIR)	Mar 16	7.68	0.00	0.00%
102. PDLI				SUPER BUY - PDL BioPharma, Inc. (NasdaqNM : PDLI)	Mar 16	6.59	0.00	0.00%
103. PGNX				SELL - Progenics Pharmaceuticals Inc. (NGM : PGNX)	Mar 16	5.36	0.00	0.00%
104. POZN				BUY - Pozen, Inc. (NGM : POZN)	Mar 16	6.97	0.00	0.00%
105. PRGO				SUPER BUY - Perrigo Company (NasdaqNM : PRGO)	Mar 16	51.52	0.00	0.00%
106. PTIE				SELL - Pain Therapeutics (NasdaqNM : PTIE)	Mar 16	6.18	0.00	0.00%
107. QGEN				SUPER BUY - Qiagen N.V. (NasdaqNM : QGEN)	Mar 16	22.81	0.00	0.00%
108. QLTI				BUY - QLT Inc. (NasdaqNM : QLTI)	Mar 16	4.96	0.00	0.00%
109. REGN				BUY - Regeneron Pharmaceuticals, Inc. (NasdaqNM : REGN)	Mar 16	24.76	0.00	0.00%
110. RIGL				BUY - Rigel Pharmaceuticals, Inc. (NGM : RIGL)	Mar 16	8.24	0.00	0.00%
111. SEPR				HOLD - Sepracor Inc. (NasdaqNM : SEPR)	N/A	22.85	0.00	0.00%
112. SGEN				BUY - Seattle Genetics, Inc. (NGM : SGEN)	Mar 16	12.11	0.00	0.00%
113. SGMO				SUPER BUY - Sangamo BioSciences, Inc. (NGM : SGMO)	Mar 16	5.97	0.00	0.00%
114. SHPGY				HOLD - Shire plc (NasdaqNM : SHPGY)	Mar 16	67.31	0.00	0.00%
115. SLXP				BUY - Salix Pharmaceuticals, Ltd. (NasdaqNM : SLXP)	Mar 16	30.64	0.00	0.00%
116. SNTA				HOLD - Synta Pharmaceuticals Corp. (NGM : SNTA)	Mar 16	4.69	0.00	0.00%
117. SNTS				BUY - Santarus, Inc. (NGM : SNTS)	Mar 16	4.72	0.00	0.00%
118. SQNM				BUY - Sequenom, Inc. (NGM : SQNM)	Mar 16	6.08	0.00	0.00%
119. STEM				HOLD - StemCells, Inc. (NGM : STEM)	Mar 16	1.21	0.00	0.00%
120. SUPG				HOLD - SuperGen, Inc. (NGM : SUPG)	Mar 16	3.15	0.00	0.00%
121. SVNT				SUPER BUY - Savient Pharmaceuticals Inc (NGM : SVNT)	Mar 16	15.10	0.00	0.00%
122. TECH				BUY - Techne Corporation (NasdaqNM : TECH)	Mar 16	65.87	0.00	0.00%
123. TELK				BUY - Telik, Inc. (NCM : TELK)	Mar 16	0.85	0.00	0.00%
124. TEVA				SUPER BUY - Teva Pharmaceutical Industries (NasdaqNM : TEVA)	Mar 16	60.34	0.00	0.00%
125. THRX				HOLD - Theravance, Inc. (NGM : THRX)	Mar 16	12.57	0.00	0.00%
126. TRMS				HOLD - Trimeris, Inc. (NGM : TRMS)	Mar 16	2.47	0.00	0.00%
127. UTHR				BUY - United Therapeutics Corporation (NasdaqNM : UTHR)	Mar 16	56.98	0.00	0.00%
128. VNDA				HOLD - Vanda Pharmaceuticals Inc. (NGM : VNDA)	Mar 16	12.14	0.00	0.00%
129. VPHM				BUY - ViroPharma Incorporated (NasdaqNM : VPHM)	Mar 16	13.48	0.00	0.00%
130. VRTX				BUY - Vertex Pharmaceuticals Incorpor (NasdaqNM : VRTX)	Mar 16	43.71	0.00	0.00%
131. VRUS				SUPER BUY - Pharmasset, Inc. (NGM : VRUS)	Mar 16	26.44	0.00	0.00%
132. VVUS				SUPER BUY - VIVUS, Inc. (NGM : VVUS)	Mar 16	9.18	0.00	0.00%
133. WCRX				SUPER BUY - Warner Chilcott Limited (NasdaqNM : WCRX)	Mar 16	25.84	0.00	0.00%
134. XNPT				HOLD - XenoPort, Inc. (NasdaqNM : XNPT)	Mar 16	9.16	0.00	0.00%
135. XOMA				SELL - XOMA Ltd. (NGM : XOMA)	Mar 16	0.55	0.00	0.00%
136. ZGEN				BUY - ZymoGenetics, Inc. (NGM : ZGEN)	Mar 16	5.87	0.00	0.00%
3/17/2010 StockRing Buy-Sell-Hold ratings for NASDAQ Biotechnology Index stocks
StockRing advise: SELL 10% or 13, HOLD 33% or 45, BUY 57% or 78 of NASDAQ Index stocks
All Sell & Super Sell Sell Super Sell Hold Buy & Super Buy Buy Super Buy
Last Changes: Wed, Mar 17, 2010

3/17/2010 StockRing Business News about NASDAQ-BIO Stock Market Index

Earthtimes (press release)

Cubist Pharmaceuticals President and CEO Michael Bonney Honored by ...
MarketWatch (press release)
"Mike is truly committed to supporting each and every aspect of the biotechnology ecosystem here in Massachusetts, and Cubist's success under his leadership ...
News and FDA Updates for AP Pharma (NASDAQ:APPA), BioSante (NASDAQ:BPAX ...American Chronicle

all 19 news articles »

ICON Continues Asia-Pacific Expansion with New Office in Manila, Philippines
MarketWatch (press release)
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. ...

and more »

Sequenom stock leads downward biotech trend
MarketWatch
Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX) shares fell 9.9% to $1.28 after the biotech company Tuesday priced a secondary public offering of 87.7 million ...

and more »

Generex Oral-lyn(TM) Presentation at CODHy Congress
CNNMoney.com (press release)
WORCESTER, Mass., March 16, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for ...
Generex Oral-lyn(TM) Presentation at CODHy CongressFOXBusiness

all 8 news articles »

Aveo Pharmaceutical shares drop in trading debut
Washington Post
The Cambridge, Mass., biotechnology company's lead product candidate is now in last-stage development as a renal cell cancer treatment.
AVEO Pharmaceuticals IPO prices below expectationsWBOC TV 16

all 230 news articles »

Goldman Bullish on Biotech Names ALXN, ONXX
ONN.tv
ONXX has a market cap of $1.9 billion and is 1.4% of the iShares Nasdaq Biotechnology ETF (NYSE: IBB). I've been writing about the M&A wave in the biopharma ...

Northrop Grumman and Luminex Collaborate to Create Next Generation Autonomous ...
PR Newswire (press release)
xMAP Technology is used throughout scientific research, drug discovery and clinical diagnostics, as well as in biodefense and agro-biotechnology. ...

and more »

OSI Pharmaceuticals' Board of Directors Unanimously Rejects Astellas ...
MarketWatch (press release)
We believe that OSI is a unique asset -- the only profitable, mid-cap biotech company with a growing, high quality and fully integrated oncology franchise ...
OSI CEO Goddard Rejects Astellas on Tarceva PromiseBusinessWeek
Astellas Proposes OSI Directors in $3.5 Billion BidBloomberg

all 220 news articles »

Cytokinetics Announces Changes to Its Board of Directors
CNNMoney.com (press release)
From 1989 to 1998, he held roles of increasing responsibility at Genetics Institute, Inc., one of the pioneers in the biotechnology industry, first as head ...

and more »

EHSI Signs Option with Biotech Firm Celulas Genetica
MarketWatch (press release)
Stem cell research stocks in the Biotechnology sector that give context to the importance this exploding industry include ViaCell (NASDAQ: VIAC), ...

and more »

Mass. biotech firm faces delisting from Nasdaq (Boston Globe) A Massachusetts biotechnology that produces drugs made from the milk of genetically-engineered goats says it expects to be delisted from the Nasdaq next week.

EHSI Signs Option with Biotech Firm Celulas Genetica (Business Wire via Yahoo! Finance) HOUSTON----Emerging Healthcare Solutions, Inc. announced today that it locked down an option for a profit participation deal with biotech firm Celulas Genetica. Celulas Genetica works to develop new major medical solutions using adult stem cell research.

Cubist Pharmaceuticals President and CEO Michael Bonney Honored by Massachusetts Biotechnology Council with its 2010 ... (Business Wire via Yahoo! Finance) LEXINGTON, Mass.----Cubist Pharmaceuticals, Inc. today announced that its President and CEO Michael Bonney will be honored with the second annual Massachusetts Biotechnology Council Innovative Leadership Award.

Biotech Stock Alert for Novavax Inc. Issued by StockPreacher (GlobeNewswire via Yahoo! Finance) DALLAS -- StockPreacher.com announces an investment report featuring Novavax Inc. . The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

Astellas Proposes OSI Directors in $3.5 Billion Bid (Update3) (Bloomberg) March 16 (Bloomberg) -- Astellas Pharma Inc. nominated a 10-person slate to replace the board of U.S. company OSI Pharmaceuticals Inc. after directors urged investors to reject the Japanese drugmaker’s $3.5 billion hostile takeover.

AVI BioPharma Announces Fourth Quarter and Full Year 2009 Financial Results (Marketwire via Yahoo! Finance) BOTHELL, WA--(Marketwire - 03/16/10) - AVI BioPharma, Inc. (NASDAQ: AVII - News ), a developer of RNA-based drugs, today reported financial results for the three and twelve months ending December 31, 2009. "We've achieved significant progress over the past year. Our DMD program delivered the first clinical evidence of efficacy in two trials and our biodefense business, based on past successes ...

BioMarin, Buck are core of growing sector (Marin Independent Journal) Marin County's biotechnology sector is tiny compared with the South Bay biotech hub, but conditions are ripe for growth, local economic experts say.

Sigma-Aldrich Reaches Agreement To Sell Pfizer's Bioactive Small Molecule Compounds (PharmaceuticalOnline) Sigma-Aldrich(R) (Nasdaq: SIAL) today announced that it has entered into an agreement with Pfizer under which Sigma-Aldrich will sell approximately 100 Pfizer-developed small molecule compounds to life science researchers for target characterization, assay development, screening and in vivo animal model applications.

Domain Associates Portfolio Co. Tobira Therapeutics Closes on $4M - cbl (citybizlist Philadelphia) By citybizlist Staff PRINCETON , N.J. -- According a Reg D filing with the U.S. Securities and Excha...

Press Release (PharmiWeb) OSI Pharmaceuticals Inc. Posted on:15 Mar 10 OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) today announced that its Board of Directors, after careful review and consideration with the assistance of OSI’s management and outside legal and financial advisors, has unanimously rejected the unsolicited, conditional tender offer from Astellas US Holding, Inc., a wholly-owned subsidiary of Astellas Pharma ...

   1. World Markets - 72 Indexes on 3/8/2010:  Buy   76% or 53 Hold   3% or 2 Sell   21% or 15 indexes 2. Dow Jones Index - 30 Stocks on 3/5/2010:  Buy   57% or 17 Hold   30% or 9 Sell   13% or 4 stocks
3. Best Brands - 200 stocks on 2/17/2010:  Buy   81% or 162 Hold   -1% or -2 Sell   20% or 39 stocks
4. S&P 500 Index - 500 Stocks on 7/21/2009:   Buy   68% or 341 Hold   21% or 106 Sell   11% or 53 stocks
5. S&P 400 Mid Cap - 400 Stocks on 7/21/2009:  Buy   73% or 292 Hold   15% or 61 Sell   12% or 47 stocks
6. S&P 600 Small Cap - 600 Stocks on 4/18/2009:  Buy   28% or 168 Hold   71% or 426 Sell   1% or 6 stocks
7. Nasdaq 100 Index - 100 Stocks on 7/21/2009:  Buy   75% or 75 Hold   17% or 17 Sell   8% or 8 stocks
8. Nasdaq Telecom - 164 Stocks on 7/24/2009:  Buy   49% or 81 Hold   35% or 56 Sell   16% or 27 stocks
9. Nasdaq Biotech - 136 Stocks on 7/24/2009:  Buy   57% or 78 Hold   33% or 45 Sell   10% or 13 stocks
10. Nasdaq Computer - 440 Stocks on 7/22/2009:  Buy   60% or 263 Hold   26% or 115 Sell   14% or 62 stocks
11. Nasdaq Finance - 180 Stocks on 7/24/2009:  Buy   61% or 109 Hold   6% or 12 Sell   33% or 59 stocks
12. NYSE International - 100 Stocks on 7/21/2009:  Buy   58% or 58 Hold   34% or 34 Sell   8% or 8 stocks
13. Legg Mason Mutual - 346 Funds on 10/6/2009:  Buy   38% or 133 Hold   51% or 176 Sell   11% or 37 funds
14. T. Row Price Mutual - 161 Funds on 10/6/2009:  Buy   52% or 84 Hold   46% or 73 Sell   2% or 4 funds
15. London FTSE 100 - 94 Stocks on 4/1/2009:  Buy   20% or 19 Hold   50% or 47 Sell   30% or 28 stocks
16. Canada Toronto - 209 Stocks on 4/18/2009:  Buy   53% or 111 Hold   34% or 70 Sell   13% or 28 stocks

                                             TOTAL RATINGS:   Buy   75% or 2183 Hold   5% or 1231 Sell   20% or 514 stocks

Receive FRESH Daily Updates for 16 StockRing Reports for $30/month !!!